Actinium Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference

On September 5, 2019 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium"), reported that it will present at the Rodman & Renshaw 21st Annual Global Investment Conference (Press release, Actinium Pharmaceuticals, SEP 5, 2019, View Source [SID1234539314]). The conference is being held at the Lotte New York Palace Hotel in New York City on September 8-10, 2019. Details of Actinium’s presentation are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, September 10, 2019
Time: 4:40 PM ET
Room: Holmes I (4th Floor)
Venue: Lotte New York Palace Hotel

Members of Actinium’s Executive team will be available for 1-on-1 meetings with conference attendees. Those interested in scheduling a meeting with Actinium may do so by contacting Steve O’Loughlin, Actinium’s Principal Financial Officer via email at [email protected].

Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference

On September 5, 2019 Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, reported it will present a corporate overview at the 21st Annual H.C. Wainwright Global Investment Conference to be held September 8-10 in New York, NY (Press release, Aeglea BioTherapeutics, SEP 5, 2019, View Source [SID1234539313]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details

Date: Monday, September 9, 2019
Time: 5:30 p.m. ET
Presenter: Anthony G. Quinn, M.B. Ch.B., Ph.D., Aeglea’s president and chief executive officer
Location: Lotte New York Palace Hotel, New York
Webcast: http://ir.aegleabio.com/events/event-details/hc-wainwright-co-21st-annual-global-investment-conference

To access the live and archived audio webcast, visit the Presentations & Events section of the Aeglea BioTherapeutics investor relations website. Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. Replays of the webcast will be available for 30 days thereafter.

KemPharm to Present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.

On September 5, 2019 KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that its president and chief executive officer, Travis C. Mickle, Ph.D., will present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co. being held September 8-10, 2019, at the Lotte New York Palace Hotel (Press release, KemPharm, SEP 5, 2019, http://investors.kempharm.com/news-releases/news-release-details/kempharm-present-21st-annual-global-investment-conference [SID1234539312]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of KemPharm’s presentation are as follows:

Event: 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.
Date: Monday, September 9, 2019
Time: 2:35 PM ET
Location: Lotte New York Palace Hotel, New York, NY
The presentation will be webcast and available on the Investor Relations section of the Company’s website at View Source

Oncolytics Biotech® to Present at the H.C. Wainwright 21st Annual Global Investment Conference

On September 5, 2019 Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, reported that Kirk Look, Chief Financial Officer of Oncolytics Biotech, will present at the H.C. Wainwright 21st Annual Global Investment Conference at 5:30 pm Eastern Time on Monday, September 9, 2019 (Press release, Oncolytics Biotech, SEP 5, 2019, View Source [SID1234539311]). The conference is being held September 8-10, 2019 at the Lotte New York Palace Hotel.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio link to the webcast session will be available on the Company’s website at View Source It is recommended that listeners log on 10 minutes in advance of the live session to register and download any necessary software. An audio replay will be accessible approximately two hours following the presentation on the Oncolytics website.

VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference

On September 5, 2019 VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported that Jeff Baxter, President and CEO, will present at the H.C. Wainwright 21st Annual Global Investment Conference in New York City on Tuesday, September 10, 2019, at 8:20 AM ET (Press release, VBI Vaccines, SEP 5, 2019, View Source [SID1234539310]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

- Event: H.C. Wainwright 21st Annual Global Investment Conference
- Date: Tuesday, September 10, 2019
- Time: 8:20 – 8:45 AM ET
- Webcast: View Source

A live webcast of the presentation may also be accessed by visiting the Investors page of VBI’s website at www.vbivaccines.com.